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Antigenic drift and shift involving the surface proteins of Influenza virus gave rise to new strains that caused epidemics affecting 
millions of people worldwide over the last hundred years. Variations in the membrane proteins like Hemagglutinin (HA) and 
Neuraminidase (NA) necessitates new vaccine strains to be updated frequently and poses challenge to effective vaccine design.  
Though the HA protein, the primary target of the human immune system, has been well studied, reports on the antigenic 
variability in the other membrane protein NA are sparse. In this paper we investigate the molecular basis of antigenic drift in the 
NA protein of the Influenza A/H3N2 vaccine strains between 1968 and 2009 and proceed to establish correlation between antigenic 
drift and antigen-antibody interactions. Sequence alignments and phylogenetic analyses were carried out and the antigenic 
variability was evaluated in terms of antigenic distance. To study the effects of antigenic drift on the protein structures, 3D 
structure of NA from various strains were predicted. Also, rigid body docking protocol has been used to study the interactions 
between these NA proteins and antibody Mem5, a 1998 antibody.  
 






Influenza is a major cause for concern worldwide due to the 
human suffering and economic burden afflicted by the periodic 
epidemics. The occurrence of repeated epidemics is attributed 
to effective evasion of herd immunity in host populations by 
the Influenza A viruses through antigenic variation in the 
surface proteins. Influenza A viruses have two surface 
glycoproteins– hemaglutinin (HA) and neuraminidase (NA). 
The antigenic variations in HA and NA proteins necessitate 
new vaccine strains to be updated frequently and hence 
constitutes a major challenge to effective vaccine design [1]. 
Though the antigenic variability of the HA protein has been 
studied  [2-5], reports related to antigenic variability of NA 
protein are rare. This may be due the fact that the NA protein, 
by the virtue of its positioning on the virus membrane, has 
somewhat limited interactions with the host immune system 
[6]. The Neuraminidase is a mushroom-shaped tetrameric 
protein, anchored to the viral membrane by a single sequence of 
29 amino acid length at the N-terminus [7]. The four identical 
subunits are arranged with circular four fold symmetry and the 
enzyme active site is located centrally on each subunit. It is 
evident from reports that the anti-NA antibodies do provide 
protection and arguments have been made that NA should be 
included in the vaccines [8, 9]. However, direct demonstration 
of a significant contribution of NA to antigenic drift in human 
influenza viruses has not been made so far. There are instances 
of outbreaks due to failure of HA based vaccine. The 2003-2004 
epidemic of H3N2 was caused by the proliferation of a new 
H3N2 subtype strain A/Fujian/411/2002 (an antigenic drift 
mutant of the A/Panama/2007/99 strain), with the existing 
vaccine failing to offer any protection [1, 10]. Hence, studies on 
antigenic variability in the NA protein are necessitated.   
 
Though antigenic evolution of H3N2 has been studied in terms 
of HA protein, to the best of our knowledge reports involving 
NA protein of H3N2 viruses are sparse. In our earlier BIOINFORMATION  open access 
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publication  [11], we have reported about the antigenic 
variability in H3N2 virus strains (1968-2007) in the light of 
antigen-antibody interactions involving HA proteins. In the 
present paper, we studied the antigenic variability of NA 
proteins of influenza A/H3N2 (vaccine strains 1968-2009) using 
bioinformatics tools for sequence and structural analysis. Using 
modelling and docking protocols we also investigated the 
molecular basis of the reported (experimental evidence) failure 
of antibody Mem5 (raised against A/Memphis/31/98 NA 
protein and specific to epitope B) to bind to H3N2 strains 
evolving in 1999 and thereafter [12]. 
 
Methodology: 
The dataset:  
The NA amino acid sequences for the following WHO 
recommended vaccine strains of influenza A/H3N2 virus were 
downloaded from the SwissProt database: A/Aichi/2/1968 
(X31), A/Albany/1/1970 (ALB70), A/Port Chalmers/1/1973 
(PC73), A/Memphis/31/98 (MP98), A/Moscow/10/1999 
(MOS99),  A/Wisconsin/67/2005  (WIS05), 
A/Brisbane/10/2007  (BR07) and A/Perth/16/2009 (PT09). The 
names in parenthesis will be used henceforth in the present 
paper. The structural information for Neuraminidase protein 
was retrieved from the Protein Databank (PDB ID:  2AEP). This 
known structure of MP98 NA protein complexed with antibody 
Mem5 has been considered as a reference for the study.    
 
Phylogenetic analyses: 
Sequence-based phylogenetic analyses were carried out using 
the Molecular Evolutionary Genetic Analyses (MEGA 4.0) 
package  [13]. Multiple sequence alignment was carried out 
using the ClustalW implementation in MEGA 4.0 with default 
parameters. The phylogenetic tree was constructed using the 
neighbor-joining algorithm and bootstrap with 10,000 
replications was used as test of phylogeny. To obtain the 
pairwise comparison of sequences (all possible combinations) 
within the dataset, the ALIGN algorithm as implemented in 
ISHAN package [14] has been used.  
 
Antigenic variability: 
In silico prediction of antigenic determinants was performed for 
each sequence of the dataset using the Kolaskar method [15] as 
implemented in the B-cell epitope prediction server at Immune 
Epitope Database (IEDB; www.immuneepitope.org/). The 
known antigenic regions [15] w e r e  a l s o  c o m p a r e d  w i t h  t h e  
predictions. The antigenic distance between any two strains 
(newer vs older) can be measured in terms of the fraction of 
amino acids differing between the strains in the epitope regions.  
Such a measure is defined by pepitope  [1]. It is calculated as 
follows:  pepitope = Number of amino acid differences in the 




Figure 1: (A) Antigenic distances of all the epitopes (A, B and C) on NA proteins from selected vaccine strains of Influenza 
A/H3N2 computed with X31 as a standard. (B) Antigenic distances of all the epitopes (A, B and C) on NA proteins between 
successive strains of Influenza A/H3N2. (C) The comparison of surface electrostatics (outputs from NOC program) reveals 
dissimilarities between the MP98, MOS99 and WIS05 arising due to mutations in the epitope B. Numbering of amino acids are in 
accordance with sequence numbering of X31 (sequence ID: Q75VQ4). BIOINFORMATION  open access 
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3D structure prediction and analyses: 
The 3D structures of the NA proteins from strains MOS99 and 
WIS05 have been predicted using the SwissModel online 
workstation. The template chosen (based on the automatic 
template selection mode) was the NA protein of MP98 (PDB ID: 
2AEP.pdb). Energy minimization of the modeled structures and 
structural comparisons were performed using the GROMOS96 
force field application in Swiss PDB-Viewer (SPDBV) [16]. 
Predicted 3D structures were evaluated using PROCHECK 
analyses  [17]. Visualization of molecular structures and 
rendering of images was carried out in Discovery Studio v.2.0 
(Accelyrs Inc., USA). The NOC software was used for studying 
the surface electrostatics of the proteins structures [18]. 
 
Molecular docking: 
Computational rigid-body docking protocol, a method which 
predicts the preferred stable orientation of one molecule when 
bound to a second one, was used to determine the binding site 
and the residues interacting between the antigens and antibody 
through hydrogen bonds (H-bonds) and salt bridges. In silico 
docking of antibody Mem5 against the NA proteins of MOS99 
and WIS05 has been carried out using the ZDOCK server with 
default parameters [19]. No preconditions such as, specific 
amino acids desired to be at the interface, were specified at the 
time of running the docking protocol. From ten solutions 
returned by ZDOCK in each case, the best solution was selected 
based on the following conditions: i) the complimentarity 
determining regions (CDRs)  of the antibody interacting with 
the antigen at the antigen-antibody interface and ii) the value of 
minimized energy of the complex being the least. The details of 
contacts between amino acids of antigen and antibody for each 
complex were obtained by Contacts of Structural Units (CSU) 
analyses [20].  
 
Discussion:  
Neuraminidase amino acid sequences from various strains were 
subjected to pairwise comparison using the ISHAN package 
[14]. Identity (%) values calculated from these alignments were 
tabulated by the program (Figure S1, see Supplementary 
material). Maximum identity (99.4%) in amino acid 
composition was observed between the strains BR07 and PT09. 
The minimum identity (85.5%) was observed between X31 and 
PT09. The net divergence within NA sequences considered in 
the study (time span: 1968-2009) was found to be 8.1%. Also, 
analyses based on earlier reports [11], revealed that divergence 
between the HA sequences was 8.6% over the similar time span. 
Phylogenetic analyses further indicated clustering of the 
sequences and placed both BR07 and PT09 in one clade (Figure 
S2, see Supplementary material). The multiple sequence 
alignment indicated the occurrence of mutations in the various 
strains with respect to X31. Compared to the X31 there were 16, 
27, 53, 56, 63, 66 and 67 mutations in the sequences ALB70, 
PC73, MP98, MOS99, WIS05, BR07 and PT09 respectively 
(Figure S3, see Supplementary material). The number of 
m u t a t io n s  b e t w e e n  B R 0 7  a n d  PT 0 9  w e re  f ou n d  t o  b e  o n l y  3 .  
These mutations were not in the epitopes or their vicinity.  The 
amino acid stretches which recorded maximum variations in 
composition are: i) 140-155 and ii) epitope C covering 329-347 & 
357-370 (as per numbering of complete amino acid sequences in 
Figure S3, see Supplementary material). 
 
The antigenic evolution has been evaluated in terms of 
mutations in the epitope regions. Figure 1A describes the 
antigenic distances of various strains with respect to X31, for 
the known epitopes A, B, and C. The antigenic distance was 
determined in terms of pepitope. It can be seen from the graph that 
antigenic distance is least between the strains X31 and ALB70 
with no mutations in the epitopes A and C. Comparatively, the 
antigenic distance is higher between X31 and PC73 with many 
mutations in the epitope regions. The antigenic distances of 
MP98, MOS99, WIS05, BR07 and PT09 with respect to X31 are 
high for all the epitopes. Maximum antigenic variability is 
observed in the epitope C within the data set considered 
(Figure 1A). The total number of mutations between the 
successive strains has been enlisted in Table 1 (see 
Supplementary material).  Figure 1B describes the antigenic 
distances between pairs of NA proteins from successive strains. 
While only the epitope B changed between the strains X31 and 
ALB70, all the epitopes differed between ALB70 and PC73. It 
should be noted that between the strains of MP98 and MOS99, 
variability was observed in epitopes B and C (pepitope values: 0.19 
and 0.48 respectively). No changes were observed in any of the 
epitopes of NA protein between the strains BR07 and PT09. In 
order to investigate the molecular basis of the reported failure 
of Mem5 antibody (which is specific to epitope B of MP98) to 
bind to NA of strains evolved in 1999 and thereafter [12], we 
undertook molecular docking studies involving the known 
structure of Mem5 against predicted 3D structures of NA 
proteins. Three dimensional structures of the NA proteins from 
strains MOS99 and WIS05 were predicted using the homology 
modelling protocol as implemented by SwissModel online 
workstation (automated mode). The NA protein of influenza 
(H3N2) strain MP98 was used as a template (PDB ID: 2AEP). 
Analyses of energy values and Ramachandran plot revealed 
that the models were reliable (Table 2, see Supplementary 
material). Docking of Mem5 antibody onto the 3D structures of 
NA proteins was carried out to determine the binding site and 
the residues interacting within the antigen-antibody complex 
through hydrogen bonds (H-bonds) or salt bridges.  
 
The results of docking studies indicated that the antibody 
Mem5 failed to recognize and bind to the epitope B on the NA 
protein of MOS99 and strains evolved thereafter. Docking 
outputs revealed physically unrealistic orientations of antigen 
with antibody (Figure S4, see Supplementary material). The 
docking output revealed that Mem5 docked onto NA of MOS99 
with the CDR regions interfacing with the amino acid stretch 
170-176 on MOS99 but without H-bonds. However, this region 
on the NA would remain embedded in the tetramer complex on 
the virion surface and therefore remain inaccessible to 
antibodies, as observed in the tetrameric structure of NA 
protein (PDB ID: 2AEP) (Figure S4B, see Supplementary 
material). The failure of the antibody to recognize epitope B on 
the NA of MOS99 can be attributed to the variations in amino 
acid composition (greater antigenic distance). The mutation 
H197D at the antigenic site B in MOS99 compared to MP98 
resulted in alteration of molecular surface contour as well as 
electrostatics  (Figure 1C). This mutation was retained in the 
subsequent strains WIS05, BR07 and PT09.  The amino acid 
H197 of NA MP98 was crucial for interactions with the 
Antibody Mem5. In the co-crystal structure of Mem5 with NA 
of MP98 (2AEP.pdb), the residue H197 on epitope B formed H-
bonds with residues R52 and T56 of the heavy chain of Mem5 BIOINFORMATION  open access 
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(data obtained from CSU [20] analyses).  Hence, the mutation 
H197D has not only altered the surface electrostatics, but also 
altered the ability to form H-bonds with the antibody. Another 
two mutations E199K and K221E at the epitope B were 
observed in WIS05 and retained thereafter. These mutations 
along-with another one G216V in the vicinity of epitope B, 
further altered the side-chain conformation (protein surface) 
and the surface electrostatics (Figure 1C). From predominantly 
negatively charged in MOS99, the epitope B has become 
predominantly positive in WIS05. However, in the absence of 
suitable antibody structures (1999 onwards) it was impossible 
to ascertain the impacts of these mutations in terms of antigen-
antibody interactions.  
 
Overall, antigenic variability in NA proteins between the 
various strains of H3N2 viruses have been studied. Though the 
e p i t o p e s  o f  A L B 7 0  w e r e  v e r y  s i m i l a r  t o  t h a t  o n  X 3 1 ,  
considerable differences existed between those on X31 and 
other strains evolving from 1973 onwards.  Maximum 
variability was observed in epitope B between the successive 
evolving strains during 1998-2005. The docking of Mem5, an 
antibody specific to epitope B of MP98, onto the MOS99 and 
WIS05 NAs revealed that the antibody fails to recognize the 
epitope. The loss of recognition by the antibody can be 
attributed to the mutations on the B epitope of MOS99 and 
WIS05 which altered the protein surface and the surface 
electrostatics. A comparison with earlier reports from the 
authors’ laboratory [11] revealed that the antigenic variability in 
NA followed trends similar to that in case of the HA proteins 
and also indicated the equivalent net divergence within NA 
proteins. The findings at the molecular level supports the earlier 
experimental reports related to NA and host immune response 
[8, 9].  
 
Conclusion: 
The antigenic evolution of Neuraminidase proteins from 
vaccine strains of influenza A/H3N2 has been studied over the 
period 1968-2009 and variability in terms of antigenic distances 
have been observed for all the epitopes. The structural basis for 
the antibody Mem5 not recognizing the NAs of 1999 and 
subsequently evolved strains could be explained through 
molecular docking studies. A single amino acid change was 
found to alter the surface properties, antigenicity of the epitope 
B in NA proteins and the specificity to antibody binding. The 
present study may contribute in gaining insight into the 
mechanisms of virus-host interactions at the molecular level. 
Our study supports the earlier experimental observations 
regarding NA versus host-immune response and reinforces the 
suggestions that the NA protein may be considered along with 
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Table 1: List of mutations in NA protein between successive strains 












BR07   
vs 
 PT09 
Total number of 
mutations 
16 13  9  13  9  3 
 
Table 2: Analyses of 3D structures of NA proteins 




RMSD (Å) with 
template 
Occupancy* (%) in 
Ramachandran plot 
MOS99 97.68  -21874.86  0.06  100 
WIS05 95.62  -22159.46  0.09  100 
2AEP.pdb        
(Template) 
- -21561.28  -  100 
*N.B. Occupancy in Ramachandran Plot denotes the percentage of amino acids in the favourable and generously allowed regions. 
 
 
Figure S1: Identity (%) between Influenza A/H3N2 NA amino acid sequences. Table generated as output of ISHAN package.  
 
 
Figure S2: Phylogenetic tree (Neighbor –Joining) of NA protein sequences of selected H3N2 strains (with bootstrap analysis as test 
of phylogeny with 10000 replications) as obtained from MEGA 4.0. 
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Figure S3: Multiple alignment of Neuraminidase (NA) protein sequences from H3N2 strains. Epitopes A, B and C are highlighted 
in Yellow, Pink and Cyan respectively.  
 
 
Figure S4: Physically unrealistic orientation of Antibody Mem5 (Blue) docked with NA Antigen (red) with epitope regions 
highlighted A (yellow), B (Pink) and C (Cyan) residues at the docking interface shown in (A) remain inaccessible in the natural 
tetramer of the NA protein (B). 
 
 
 
 
 
 
  
 